Identifying novel biomarkers for biliary tract cancer based on volatile organic compounds analysis and machine learning
BackgroundThe current diagnostic methods for biliary tract cancer (BTC) have limitations in sensitivity and specificity. This study aims to explore the use of volatile organic compounds (VOCs) in serum to distinguish BTC and benign biliary diseases (BBD).MethodWe collected 158 serum samples from BTC...
Saved in:
| Main Authors: | Jingrong Qian, Qi Liu, Jue Wang, Xuewei Zhuang, Jun Fang |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2025-04-01
|
| Series: | Frontiers in Oncology |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fonc.2025.1572460/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Hyponatremia predicts immunotherapy resistance in biliary tract cancer
by: Tiance Wang, et al.
Published: (2025-12-01) -
T‐Cadherin in Biliary Tract Cancer Stroma, a Potent Pharmacological Target for Biliary Tract Carcinogenesis
by: Yuki Hanamatsu, et al.
Published: (2025-04-01) -
Strictures of biliary tracts during opisthorchosis
by: N. A. Brazhnikova, et al.
Published: (2003-12-01) -
Maintenance chemotherapy in biliary tract tumours in the era of immuno-chemotherapy
by: A. Lamarca, et al.
Published: (2025-03-01) -
Efficacy and safety of combining tislelizumab with capecitabine compared to capecitabine alone in the adjuvant treatment of biliary tract cancers: rationale and protocol design for a randomized clinical trial
by: Xubiao Wei, et al.
Published: (2025-05-01)